Fintech

Novo Nordisk says Wegovy pill outperforms Lilly’s oral GLP-1 in cross-trial comparison

Cnbc·April 2, 2026 at 12:00 PM

Novo and Eli Lilly are both trying to shape the narrative of their rival pills, considered to be the start of the next phase of the weight-loss drug era.

Original Source

Cnbc — www.cnbc.com

Related in Fintech

DOJ crypto memo author named interim AG
CoinDesk
Drift crypto exchange remains frozen after attack
PYMNTS
Amazon adds fuel surcharge for sellers
PYMNTS
DOJ Appeals Anthropic AI Ban Restoration
PYMNTS

Novo Nordisk says Wegovy pill outperforms Lilly’s oral GLP-1 in cross-trial comparison

DOJ crypto memo author named interim AG

Drift crypto exchange remains frozen after attack

Amazon adds fuel surcharge for sellers

DOJ Appeals Anthropic AI Ban Restoration